Y. Rimmer

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers

Ozan Oktay, Jay Nanavati, Anton Schwaighofer et al. · JAMA Network Open · 2020 · 78 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

David P. Dearnaley, Clare Griffin, Rebecca Lewis et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Practical Aspects of Implementation of Helical Tomotherapy for Intensity-modulated and Image-guided Radiotherapy

N.G. Burnet, Elizabeth Adams, J. Fairfoul et al. · Clinical Oncology · 2010 · 59 citations

Medicine, Oncology, Radiation Oncology +16